A Retrospective Analysis of Diagnostic Breast Imaging Outcomes in Young Women at a Tertiary Care Center.


Journal

Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503

Informations de publication

Date de publication:
06 Jul 2024
Historique:
received: 22 05 2024
revised: 29 06 2024
accepted: 03 07 2024
medline: 26 7 2024
pubmed: 26 7 2024
entrez: 26 7 2024
Statut: epublish

Résumé

(1) Purpose: The purpose of this study was to describe the outcomes of diagnostic breast imaging and the incidence of delayed breast cancer diagnosis in the study population. (2) Methods: We collected the outcome data from diagnostic mammograms and/or breast ultrasounds (USs) performed on women between the ages of 30 and 50 with symptomatic breast clinical presentations between 2018 and 2019. (3) Results: Out of 171 eligible patients, 10 patients (5.8%) had BIRADS 0, 90 patients (52.6%) had benign findings (BIRADS 1 and 2), 41 (24.0%) patients had probable benign findings requiring short-term follow-up (BIRADS 3), while 30 (17.5%) patients had findings suspicious of malignancy (BIRADS 4 and 5). In the BIRADS 3 group, 92.7% had recommended follow-up, while in BIRADS 4 and 5, only 83.3% underwent recommended biopsy at a mean time of 1.7 weeks (range 0-22 wks) from their follow-up scan. Ten (6%) patients were diagnosed with breast cancer, all of whom had BIRADS 4 or 5, with a mean time of breast cancer diagnosis from initial diagnostic imaging of 2.2 weeks (range 1-22 wks). No patients had delayed breast cancer diagnosis in our cohort. (4) Conclusions: We conclude that diagnostic mammograms and breast US are appropriate investigations for clinical breast concerns in women aged 30-50 years.

Identifiants

pubmed: 39057163
pii: curroncol31070291
doi: 10.3390/curroncol31070291
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3939-3948

Auteurs

Navdeep Dehar (N)

Department of Oncology, Queen's School of Medicine, Queen's University, Kingston, ON K7L 5P9, Canada.
Cancer Centre of Southeastern Ontario, Kingston Health Sciences Centre, Kingston, ON K7L 2V7, Canada.

Doris Jabs (D)

Department of Oncology, Queen's School of Medicine, Queen's University, Kingston, ON K7L 5P9, Canada.
Cancer Centre of Southeastern Ontario, Kingston Health Sciences Centre, Kingston, ON K7L 2V7, Canada.

Wilma Hopman (W)

KGH Research Institute, Department of Public Health Sciences, Queen's University, Kingston, ON K7L 3N6, Canada.

Mihaela Mates (M)

Department of Oncology, Queen's School of Medicine, Queen's University, Kingston, ON K7L 5P9, Canada.
Cancer Centre of Southeastern Ontario, Kingston Health Sciences Centre, Kingston, ON K7L 2V7, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH